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RCC1-dependent activation of Ran accelerates 
cell cycle and DNA repair, inhibiting DNA 
damage–induced cell senescence
ABSTRACT The coordination of cell cycle progression with the repair of DNA damage sup-
ports the genomic integrity of dividing cells. The function of many factors involved in DNA 
damage response (DDR) and the cell cycle depends on their Ran GTPase–regulated nuclear–
cytoplasmic transport (NCT). The loading of Ran with GTP, which is mediated by RCC1, the 
guanine nucleotide exchange factor for Ran, is critical for NCT activity. However, the role of 
RCC1 or Ran⋅GTP in promoting cell proliferation or DDR is not clear. We show that RCC1 
overexpression in normal cells increased cellular Ran⋅GTP levels and accelerated the cell cycle 
and DNA damage repair. As a result, normal cells overexpressing RCC1 evaded DNA dam-
age–induced cell cycle arrest and senescence, mimicking colorectal carcinoma cells with high 
endogenous RCC1 levels. The RCC1-induced inhibition of senescence required Ran and ex-
portin 1 and involved the activation of importin β–dependent nuclear import of 53BP1, a 
large NCT cargo. Our results indicate that changes in the activity of the Ran⋅GTP–regulated 
NCT modulate the rate of the cell cycle and the efficiency of DNA repair. Through the essen-
tial role of RCC1 in regulation of cellular Ran⋅GTP levels and NCT, RCC1 expression enables 
the proliferation of cells that sustain DNA damage.
INTRODUCTION
Regulation of the rate at which cells divide is critical to normal devel-
opment and tissue homeostasis. Because many DNA-damaging 
events continuously challenge the genome integrity of dividing cells, 
conserved DNA damage response (DDR) signaling networks have 
evolved to coordinate DNA damage repair with the continuing cell 
cycle (Ciccia and Elledge, 2010; Smith et al., 2010). Central to DDR 
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2003; Caudron et al., 2005; Kalab et al., 2006). The NCT rates for 
all Ran system components are not known. Therefore we used the 
previously published single-compartment models of mitotic HeLa 
cells (Caudron et al., 2005; Kalab et al., 2006) to simulate the Ran 
system in rapidly dividing mitotic cells with high Ran⋅GTP levels 
(Hasegawa et al., 2013; Figure 1B). From the relative expression in 
HeLa and human fibroblasts (HFF-1; Supplemental Figure S1), we 
deduced the composition of the Ran system in slowly dividing cells 
(Hasegawa et al., 2013; Figure 1A, Supplemental Figure S1, Sup-
plemental Text S1, and Supplemental Tables S1 and S2). In both 
models, Ran⋅GTP levels were most responsive to simultaneous 
changes in Ran and RCC1 concentrations and reduced RanGAP1 
expression (Figure 1, A and B). When overexpression of individual 
factors was considered, Ran⋅GTP was most sensitive to RCC1 con-
centration in the fibroblast model (Figure 1A) and to changes in 
Ran in the HeLa model (Figure 1B). Therefore, to examine how in-
creased Ran⋅GTP levels affect the cell cycle in relatively slowly di-
viding cells, we tested RCC1 overexpression.
We chose the telomerase-immortalized normal epithelial RPE1 
cells (hTERT-RPE1WT) as a model, because these cells display inter-
mediate mitotic Ran⋅GTP gradients and Ran⋅GTP levels (Hasegawa 
et al., 2013). Because the models predicted that the effect of RCC1 
on Ran⋅GTP would saturate at low micromolar RCC1 concentrations 
(Supplemental Figure S1), we selected human phosphoglycerate 
kinase (PGK) promoter to drive moderate overexpression of RCC1 
with a C-terminal V5 tag in a stable hTERT-RPE1RCC1-V5 cell line. From 
immunoblots (Figure 1C), we estimated that the total RCC1 concen-
tration in the hTERT-RPE1RCC1-V5 cells was four to six times higher 
than in the hTERT-RPE1WT cells. Such an increase in RCC1 levels was 
similar to the difference between HFF-1 and HeLa cells (Figure 1, A 
and B, and Supplemental Figure S1), suggesting that the RCC1 
overexpression mimicked the physiologically relevant range. We 
then verified the effect of RCC1 overexpression using RBP-4, the 
Förster resonance energy transfer (FRET) biosensor for Ran⋅GTP in 
mitotic cells (Hasegawa et al., 2013). RBP-4 consists of a Ran⋅GTP-
binding domain flanked by the cyan mTFP-1 donor and a nonfluo-
rescent dsREACh acceptor (Figure 1D; Hasegawa et al., 2013). 
RBP-4 binding to Ran⋅GTP extends the donor from the acceptor, 
leading to decreased FRET efficiency (ERBP-4) and increased donor 
fluorescence lifetime (τdonor). Because the RBP-4 FRET activity de-
creases with Ran⋅GTP binding, the average (ERBP-4)−1 value could be 
used to compare the Ran⋅GTP concentration between different mi-
totic cells quantitatively (Hasegawa et al., 2013). We applied fluores-
cence lifetime imaging microscopy (FLIM) to detect the changes of 
ERBP-4 in live mitotic cells transiently expressing the RBP-4 sensor. 
The mitotic hTERT-RPE1RCC1-V5 cells displayed larger differences in 
ERBP-4 between the chromatin and cytoplasmic areas (Figure 1F) and 
higher (ERBP-4)−1 values (Figure 1G), confirming the expected in-
creased mitotic Ran⋅GTP gradients and elevated Ran⋅GTP levels. 
The compartmentalization of Ran and its regulators RCC1 and Ran-
GAP1 between the nucleus and cytoplasm precludes the direct 
measurements of Ran⋅GTP with RBP-4 FRET in interphase cells. 
However, previous studies showed that the expression of Ran, 
RCC1, and RanGAP1 remained stable during the exit from mitosis 
(Ciciarello et al., 2010), indicating that the mitotic Ran⋅GTP levels 
correspond to the Ran⋅GTP-generating activity in the interphase 
cells as well. Fluorescence-activated cell sorting (FACS) analysis 
showed that the fraction of cells in different cell cycle phases was 
not appreciably affected by RCC1 overexpression (Supplemental 
Figure S1). However, consistent with our initial hypothesis, the 
hTERT-RPE1RCC1-V5 cells proliferated significantly faster than the WT 
cells (Figure 1H; population doubling time [PDT] = 2.9 vs. 4.5 d).
Because separate signaling networks control the termination of DDR, 
the cell cycle reentry in the presence of DNA damage is also a pos-
sible outcome (Kleiblova et al., 2013; Shaltiel et al., 2015).
The activities of many factors involved in the control of cell cycle 
and DDR depend on their Ran GTPase–regulated nuclear–cytoplas-
mic transport (NCT; Pemberton and Paschal, 2005; Thompson, 
2010; Blackinton and Keene, 2014), suggesting that NCT activation 
could promote cell cycle and DDR kinetics.The driving force of NCT 
is the concentration gradient of Ran⋅GTP across the nuclear enve-
lope: nuclei contain high Ran⋅GTP concentrations, and the cytoplas-
mic Ran is mostly GDP bound. This striking Ran⋅GTP compartmen-
talization depends on the nuclear localization of RCC1, the guanine 
nucleotide exchange factor for Ran, and cytoplasmic localization of 
RanGAP1, the Ran GTP-ase–activating protein. Ran⋅GTP interacts 
with ∼20 different nuclear transport receptors (NTRs), importins, and 
exportins (Pemberton and Paschal, 2005) and regulates either the 
loading or unloading of cargoes on NTRs. Cargoes are unloaded 
from importins that bind to Ran⋅GTP in the nucleus, while Ran⋅GTP 
is required for cargo loading onto exportins before their exit to the 
cytoplasm (Pemberton and Paschal, 2005). NTR cargoes include 
myriad proteins and several classes of nucleic acids, including the 
eIF4e-dependent mRNAs for many cyclins (Culjkovic et al., 2006; 
Muqbil et al., 2013). Following disassembly of the nuclear envelope 
in mitotic cells, mitotic chromosomes are surrounded by diffusional 
Ran⋅GTP gradients, which support the assembly and function of mi-
totic spindles through the continuing dynamics of Ran⋅GTP–NTR 
interactions (Kalab et al., 2002, 2006; Forbes et al., 2015). In addi-
tion to Ran⋅GTP-dependent NCT, Ran⋅GDP functions as the nuclear 
import receptor for proteins carrying the ankyrin repeat motif (Lu 
et al., 2014).
To date, the potential role of Ran activity in controlling the rate of 
the cell cycle or DNA repair is supported only by indirect or correla-
tive evidence. Namely, since premature cell aging leads to decreased 
NCT activity (Snow et al., 2013), the reduced nuclear transport of 
various DDR factors could explain the decline in DDR function ob-
served in aging cells (Klement and Goodarzi, 2014). The requirement 
of Ran for the continuation of the cell cycle is consistent with the evi-
dence that Ran knockdown by RNA interference (RNAi) induces cell 
senescence in primary fibroblasts (Nagai and Yoneda, 2012). Fur-
thermore, we previously showed that, compared with slow-growing 
cells, rapidly proliferating tissue culture cells expressed approxi-
mately four times higher levels of RCC1 (Hasegawa et al., 2013), the 
guanine nucleotide exchange factor for Ran, suggesting the poten-
tial role of RCC1 and Ran⋅GTP in accelerating the cell cycle.
In this study, we set out to investigate the role of Ran activity in cell 
cycle and DDR regulation using RCC1 overexpression, RNAi, and 
chemical inhibitors. We manipulated the RCC1-dependent Ran⋅GTP 
levels in cells and the function of two major NTRs, importin β and 
exportin 1. Our results demonstrated that RCC1-dependent activa-
tion of Ran-regulated NCT accelerates cell cycle and DNA damage 
repair, leading to evasion of DNA damage–induced cell senescence.
RESULTS
RCC1 overexpression accelerates the cell cycle
The cellular concentration of free Ran⋅GTP available for binding to 
NTRs is critical for most known Ran-regulated functions, including 
NCT. To determine changes in Ran regulation that could lead to 
increased Ran⋅GTP levels, we applied computational modeling of 
the minimal set of proteins controlling the GTP/GDP cycle on Ran. 
Within these models, we either increased or decreased the con-
centrations of their individual components and followed the 
changes of average cellular Ran⋅GTP concentration (Gorlich et al., 
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2009). Both replicative exhaustion and doxorubicin treatment 
induced the onset of cell senescence, as indicated by the 
appearance of the senescence-associated β-galactosidase 
(SABG) staining (Debacq-Chainiaux et al., 2009; Figure 2C) and 
led to a strong decline in RCC1 expression (Figure 2B). We 
also observed lower Ran and RanBP1 levels in senescent 
HFF-1 cells and a decrease in RCC1 levels in doxorubicin-
treated Wi-38 and CRL-1474 primary hu-
man fibroblasts (Supplemental Figure S2). 
Quantification of immunoblots showed 
that, when normalized to the total cell 
protein concentration, the senescent 
HFF-1 cells contained ∼25% RCC1 com-
pared with early-passage cells (Figure 2B). 
However, because of their nearly three-
times larger volume (1.27 ± 0.07 pl, pas-
sage 8 vs. 3.57 ± 0.30 pl, passage 30 
HFF-1 fibroblasts), the late-passage cells 
contained <10% RCC1 concentration 
compared with the early-passage cells, 
confirming the strong reduction in the 
RCC1-dependent Ran⋅GTP generation in 
nondividing cells.
Ran⋅GTP levels decline in nondividing cells
If the RCC1-dependent rise of Ran⋅GTP activates cell cycle 
progression, stimuli inducing cell cycle arrest should oppose 
RCC1 by lowering its activity or expression. To test this scenario, 
we induced cell cycle arrest in HFF-1 fibroblasts by a long-
term in vitro culture or by inducing DNA damage through treat-
ment with doxorubicin (Chang et al., 2002; Sliwinska et al., 
FIGURE 1: RCC1-dependent increase in Ran⋅GTP accelerates the cell cycle. (A and B) Changes in cellular Ran⋅GTP 
concentration analyzed by computational models of the minimal Ran system in a fibroblast-like cell (A) and a HeLa-like 
cell (B). (C) Immunoblots of RCC1 in the hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cell lysates. (D) Schematic of the RBP-4 
FRET sensor for Ran⋅GTP detection with FLIM. The binding of Ran⋅GTP to RBP-4 increases the donor–acceptor distance, 
resulting in a longer donor fluorescence lifetime, τdonor. (E) Detection of mitotic Ran⋅GTP gradients in hTERT-RPE1WT and 
hTERT-ΔRPE1RCC1-V5 cells, using FLIM with RBP-4. The top row shows the donor intensity images and the bottom row 
shows the pseudocolor FLIM images. The range of the displayed values (corresponding to τdonor values) is indicated 
beneath the FLIM panels. Scale bar: 10 μm. (F) Scatter plot of the mitotic Ran⋅GTP gradients quantified as the difference 
between the cytoplasmic and chromatin E in each cell (ΔE; single-cell data; means ± SD; t test). (G) Scatter plot of the 
inverse of the average cellular RBP-4 E, which is proportional to Ran⋅GTP concentration (E−1; single-cell data; means ± 
SD; t test). (H) Cell number in cultures of hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells grown in parallel. Means ± SD from 
two experiments performed in triplicate were fitted with exponential growth equations after 2 d from the start of 
culture (dashed lines) to calculate the PDT. The null hypothesis was tested: one curve for both data sets.
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FIGURE 2: RCC1 expression declines during cell cycle arrest. (A) Immunoblotting of total cell 
lysates of HFF-1 cells harvested from early (p 8) or late (p 30) passages of in vitro culture and of 
early-passage HFF-1 cells recovering from the treatment with doxorubicin. (B) Relative tubulin-
normalized RCC1 protein expression in HFF-1 cells treated as in A (N = 3; means ± SD). 
(C) Micrographs of HFF-1 cells treated as in A and B and stained for the SABG. Scale bar: 100 μm.
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RPE1RCC1-V5 cells exposed to doxorubicin, indicating that RCC1 ex-
pression supported Ran stability in cells exposed to DNA damage 
(Figure 3A). Two months after the doxorubicin treatment, the 
hTERT-RPE1RCC1-V5 cells regained normal proliferation, while virtu-
ally no dividing cells were detectable in the hTERT-RPE1WT cell cul-
tures (Figure 3B). To monitor the progress of DNA damage repair, 
we used immunofluorescence (IF) to quantify the 53BP1 nuclear foci 
that assemble at the sites of DNA double-strand break repair (Ciccia 
and Elledge, 2010). Most of the hTERT-RPE1RCC1-V5 cells had <5 
nuclear foci after 8 d of recovery, and mitotic cells were already 
detectable (Figure 3C). In contrast, the nuclear 53BP1 foci persisted 
in nearly all doxorubicin-treated hTERT-RPE1WT cells (Figure 3C). At 
the same time, 53BP1 strongly accumulated in the cytoplasm of the 
hTERT-RPE1WT cells (Figure 3D), indicating delays in the 53BP1 nu-
clear import, which is Ran⋅GTP- and importin β–dependent (Moudry 
et al., 2012). It is possible that delays in nuclear import of cargoes 
other than 53BP1 limited the rate of DNA repair in the WT cells. 
However, these results strongly suggest that RCC1-dependent acti-
vation of NCT contributed to the efficient DNA damage repair and 
cell cycle reentry in the hTERT-RPE1RCC1-V5 cells. We observed simi-
lar differences in the response of hTERT-RPE1WT and hTERT-
RPE1RCC1-V5 cells to γ-irradiation–induced DNA damage (Supple-
mental Figure S4), showing that the effects of RCC1 overexpression 
RCC1 overexpression inhibits cell senescence
The cell cycle–promoting activity of RCC1 (Figure 1) indicated that 
increased RCC1 expression could attenuate DNA damage–induced 
cell cycle arrest. To test this idea, we compared the responses of 
hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells to doxorubicin treat-
ment. Within the first 2–4 d after doxorubicin washout, most cells 
stopped dividing in both cultures, as indicated by the disappear-
ance of interphase and mitotic markers (MCM2, Rad51, p-histone 
H3 [Ser-10] [pS10H3]). At the same time, the increase in cyclin D1 
indicated cell cycle arrest (Figure 3A), and the appearance of the 
SABG signal marked the onset of senescence (Figure 3B). The cyclin 
D1 levels remained stable, and SABG positivity increased over time 
in the hTERT-RPE1WT cells (Figure 3B). In contrast, SABG-negative 
and proliferating cells gradually prevailed in the hTERT-RPE1RCC1-V5 
cultures (Figure 3B, arrows), concomitant with increased interphase 
and mitotic markers and the decline in cyclin D1 expression (Figure 
3A). The quantitative capillary immunoblotting (Simple Western) 
analysis confirmed that, 8 d after doxorubicin treatment, hTERT-
RPE1WT cells accumulated cyclin D1, while hTERT-RPE1RCC1-V5 cells 
resumed expression of cyclin B1 (Supplemental Figure S3). As in the 
senescing fibroblasts (Supplemental Figure S2), the expression of 
Ran decreased to ∼65% in doxorubicin-treated hTERT-RPE1WT cells 
(Figure 3A). In contrast, Ran levels slightly increased in the hTERT-
FIGURE 3: RCC1 overexpression inhibits DNA damage–induced cell senescence in normal epithelial cells. 
(A) Immunoblotting of total lysates from the hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells recovering from doxorubicin 
treatment, showing the resumed expression of the cell cycle markers in the hTERT-RPE1RCC1-V5 cells. (B) Micrographs of 
cells treated as in A and stained for SABG. Scale bar: 100 μm. Arrows indicate dividing cells. (C) IF micrographs of 
γH2AX and 53BP1 staining in hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells recovering from doxorubicin. The arrow 
indicates a dividing cell. Scale bar: 10 μm. (D) Scatter plot of the cytoplasmic/nuclear ratios of the 53BP1 IF signal at 8 d 
of recovery from the doxorubicin. Individual cell data; means ± SD; t test representative of two experiments. (E) Column 
graph showing fractions of hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells that contained the indicated numbers of 53BP1 
foci per nucleus during the recovery from doxorubicin treatment. Means ± SD from two independent experiments, 
adjusted p values from two-way analysis of variance (ANOVA) with Sidak’s multiple comparison tests.
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Supplemental Figure S4), RCC1 could play 
a role in cancer cell resistance to DNA 
damage. Consistent with this idea, the ex-
pression of RCC1 was found to be acti-
vated by a superenhancer element in 
colorectal carcinoma HCT116 cells (Hnisz 
et al., 2013), which is a well-studied model 
of resistance to DNA damage–inducing 
chemotherapy (Chang et al., 2002; 
Sliwinska et al., 2009). We used several ap-
proaches to test the role of RCC1 in 
HCT116 cells.
First, we compared the effects of doxo-
rubicin on HCT116WT and an HCT116RCC1-V5 
cell line that stably expressed V5-tagged 
RCC1 (Figure 4). As previously reported 
(Chang et al., 2002; Sliwinska et al., 2009) 
the doxorubicin-treated HCT116WT cells 
initially stopped dividing, increased in size, 
and became SABG-positive (Figure 4A). 
Small, rapidly dividing, and SABG-negative 
cells prevailed in the cultures 5–7 d later 
(Figure 4A, arrows). A transient peak in cy-
clin D1 expression and a decline in S and 
G2/M markers (MCM2, pS10H3; Figure 4B, 
left) indicated a temporary cell cycle arrest. 
The phenotypic changes induced by doxo-
rubicin in the HCT116RCC1-V5 cells were sim-
ilar to those seen in the HCT116WT cells. 
However, the shorter duration of cyclin D1 
expression and earlier recovery of the S 
and G2/M markers indicated that the over-
expressed RCC1 slightly accelerated cell 
cycle reentry after DNA damage in the 
HCT116RCC1-V5 cell line (Figure 4B).
We used clonogenic assays to validate 
the role of RCC1 expression in DNA dam-
age recovery. After doxorubicin treatment, 
the fraction of colony-forming cells was 
nearly twice as high in HCT116RCC1-V5 com-
pared with HCT116WT cells (Figure 4C), 
demonstrating that RCC1 overexpression 
strongly increased cell survival following 
DNA damage. By analyzing cultures derived 
from single doxorubicin-treated HCT116WT 
cells, we found that rapidly proliferating 
clones contained RCC1 concentrations simi-
lar to the untreated HCT116 cells, in con-
trast to a slow-proliferating clone (Supple-
mental Figure S5), indicating that the 
recovery from DNA damage selects for cells 
with high RCC1 expression. The require-
ment for endogenous RCC1 expression in 
recovery from DNA damage was further 
confirmed by strongly reduced colony 
formation in the doxorubicin-treated HCT116WT cells upon RCC1 
knockdown by RNAi (Figure 4E). Based on these results, RCC1 func-
tions as the DNA damage resistance–promoting factor in HCT116 
cells, indicating a potential role of RCC1 in tumor cell proliferation in 
vivo. Indeed, previously reported RNA microarray data sets con-
tained evidence for statistically significantly higher RCC1 expression 
in ovarian (Scotto et al., 2008), colorectal (Alhopuro et al., 2012), and 
in doxorubicin-treated cells did not depend on accelerated drug 
efflux.
RCC1 promotes doxorubicin resistance in colorectal 
carcinoma cells
Because the overexpression of RCC1 prevented the onset of DNA 
damage–induced cell senescence in normal cells (Figure 3 and 
FIGURE 4: Endogenous RCC1 expression inhibits DNA damage–induced cell senescence in 
HCT116 colorectal carcinoma cells. (A) Micrographs of HCT116WT cells recovering from 
doxorubicin and stained for the SABG. Scale bar: 100 μm. Arrows indicate SABG activity–free 
cells. (B) Immunoblotting of total lysates from HCT116WT and HCT116RCC1-V5 cells recovering 
from doxorubicin treatment. (C) Scatter plot of the fractions of colony-forming HCT116WT and 
HCT116RCC-V5 cells recovering from doxorubicin. Single-culture data; means ± SD from three 
experiments performed in triplicate; t test. (D) Immunoblotting of total lysates of HCT116WT 
cells treated with control scramble or RCC1-directed RNAi. (E) Scatter plot of the fractions of 
colony-forming HCT116WT cells treated with doxorubicin, followed by control or Ran-directed 
RNAi. Single-culture data; means ± SD from two experiments with four replicates each; t-test.
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applied IF in cells that were fixed with paraformaldehyde and co-
permeabilized with Triton X-100 to detect changes in the recruit-
ment of 53BP1 to the chromatin, following DNA damage (Jackson 
and Bartek, 2009). Although the 53BP1 expression was not affected 
(Figure 5A), both RCC1 and Ran knockdowns significantly reduced 
the ratio of nuclear 53BP1 and γH2AX signals in the irradiated cells 
(Figure 5C), indicating defects in 53BP1 association with the DNA 
damage sites marked by γH2AX signal. The knockdown of Ran had 
a stronger effect (Figure 5C) and caused the virtual disappearance 
of 53BP1 foci in a fraction of cells (Figure 5B, arrows). These results 
indicate that Ran activity is required for the recruitment of 53BP1 to 
DNA double-strand breaks, which is an essential step for their sub-
sequent repair (Schultz et al., 2000; Callen et al., 2013).
Next we used inhibitors of importin β and exportin 1 to test the 
role of two major NTRs in DNA damage signaling. To that end, we 
carboplatin-resistant cervical tumors (Peters et al., 2005), compared 
with normal tissues (Supplemental Figure S6). Because moderate 
RCC1 overexpression was sufficient to accelerate cell cycle and 
DNA damage repair (Figures 1 and 3), relatively small increases in 
tumor RCC1 could correspond to the activation of Ran pathways 
restricted to the proliferative fraction of tumor cells.
Ran promotes DNA damage signaling and repair
Apart from accelerating the cell cycle, RCC1 and Ran⋅GTP could 
support the survival from DNA damage by activating DNA repair. 
Consistent with the requirement for Ran activity in DNA damage 
signaling, immunoblotting showed that the knockdown of Ran or 
RCC1 by RNAi reduced the ATM-dependent phosphorylation of his-
tone H2AX (γH2AX, Ser-139) and KAP1 (Iyengar and Farnham, 2011; 
p-KAP1, Ser-824) in γ-irradiated hTERT-RPE1WT cells (Figure 5A). We 
FIGURE 5: Ran-regulated NCT promotes the cellular response to DNA damage. (A) Immunoblotting of total cell lysates 
of hTERT-RPE1WT cells treated with control, RCC1-, or Ran-directed RNAi oligos and harvested 1 h after increasing doses 
of γ-irradiation. Notice the decreased intensity of the p-KAP1 and γH2AX signals in the RCC1 or Ran RNAi-treated cells. 
(B) IF micrographs of the γ-irradiated (5 Gy) hTERT-RPE1WT cells showing the reduced 53BP1 recruitment to the 
chromatin (arrows) upon Ran or RCC1-directed RNAi. (C) Scatter plot of the 53BP1/γH2AX IF signal ratios in cells 
treated as in B. Individual cell data; means ± SD; ANOVA with Tukey’s test. (D) IF micrographs of hTERT-RPE1RCC1-V5 cells 
pretreated with 40 μM IPZ or 500 nM KPT-330 and fixed 1 h after γ-irradiation (7.5 Gy). The inset shows the p-KAP1 
heterochromatin-associated foci (arrow). (E) Immunoblotting of total cell lysates of hTERT-RPE1WT (top panel) and 
hTERT-RPE1RCC1-V5 (bottom) cells treated with 40 μM IPZ or 500 nM KPT-330 and harvested 1 h after increasing doses of 
γ-irradiation. (F) Quantification of the tubulin-normalized p-KAP1 and γH2AX signals detected on immunoblots of total 
lysates of cells treated as described and harvested 1 h after the irradiation with 7.5 Gy. Means ± SD from two 
experiments; ANOVA with Tukey’s posttest.
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on immunoblots (Figure 6C) and 53BP1 nuclear foci in cells stained 
for IF (Figure 6D). Cell cycle arrest was also confirmed by continu-
ously low levels of Chk1 and pS10H3 (Figure 6C). Similar to hTERT-
RPE1WT cells treated with doxorubicin (Figure 3), the irradiated and 
Ran RNAi-treated hTERT-RPE1RCC1-V5 cells accumulated 53BP1 in 
the cytoplasm (Figure 6, D and E). Therefore the reduced nuclear 
import of large molecular cargoes, such as 53BP1, appears to be a 
hallmark of cells failing to complete DNA repair as a consequence 
of insufficient Ran activity. In summary, these results demonstrate 
that RCC1-dependent activation of Ran-regulated nuclear import 
and export pathways facilitated the termination of DDR and cell cy-
cle reentry.
DISCUSSION
The key finding of our study is that increased RCC1 expression ac-
celerates cell cycle progression and DNA damage repair in a mech-
anism that involves raised cellular Ran⋅GTP levels and the function of 
importin β and exportin 1. Our results indicate that the overall activ-
ity of Ran⋅GTP-regulated nuclear export and import pathways mod-
ulates the cell cycle pace and cellular responses to DNA damages. 
Many of the underlying cellular and molecular mechanisms have yet 
to be clarified. However, our results indicate that, through the role of 
Ran⋅GTP in NCT of the cell cycle and DDR regulators, the interphase 
cell cycle checkpoints are sensing the RCC1-dependent Ran⋅GTP 
levels. If the cellular Ran⋅GTP concentration reaches sufficient 
threshold, Ran⋅GTP-regulated NCT reactions approach rates that 
support normal DDR function and cell cycle transitions. Conse-
quently, DNA damage in such cells is successfully repaired, followed 
by termination of DDR and reentry into the cell cycle. If Ran⋅GTP 
levels fall below the required threshold, or a required NTR pathway 
is defective, the mechanisms of DNA repair or cell cycle reentry are 
delayed, triggering cell cycle arrest, as we documented, or possibly 
cell death.
The identity of the cell cycle transition(s) that was enabled by the 
RCC1 overexpression is an outstanding question raised by our re-
sults. Upon the induction of DNA damage, cell cycle reentry was 
induced by RCC1 in cells that exited mitosis (Figures 3 and 4), indi-
cating that, in the majority of cells, RCC1 induced DNA damage 
repair and cell cycle reentry through its interphase role in NCT. The 
transient accumulation of cyclin D1 and absence of mitotic markers 
indicated that RCC1 overexpression enabled the exit from G1/S ar-
rest. However, cells can enter senescence also from G2/M cell cycle 
arrest associated with high cyclin D1 expression (Gire and Dulic, 
2015). Moreover, single-cell imaging studies showed that the timing 
of the individual cell’s commitment to S-phase reentry from the G0/
G1 boundary depends on the mitosis-promoting signals in the pre-
ceding cell cycle (Spencer et al., 2013). Therefore it remains possible 
that, in RCC1-overexpressing cells exposed to DNA damage, acti-
vated mitotic function of Ran (Kalab and Heald, 2008; Forbes et al., 
2015) enables G2/M transition and accelerates the S-phase commit-
ment in the next cell cycle. The involvement of Ran in facilitating 
NCT of DNA replication factors (Liku et al., 2005; Ghosh et al., 2011) 
suggests that the intra S-phase cell cycle checkpoint also could be 
sensitive to the disruptions or activation of NCT as well. Because the 
WT and RCC1-overexpressing hTERT-RPE1 cells contain similar frac-
tions of cells in G1, S, and G2/M stages (Supplemental Figure S1), it 
is possible that RCC1 accelerates several cell cycle phases. Future 
research involving synchronized cells in single-cell studies with cell 
cycle markers is needed to identify the specific cell cycle transitions 
targeted by Ran activation.
Because Ran⋅GTP regulates ∼20 different NTRs, multiple NTRs 
acting in parallel could contribute to the RCC1-induced acceleration 
pretreated cells for 2 h with the exportin 1 inhibitor KPT-330 
(Muqbil et al., 2013) or the importin β inhibitor importazole (IPZ; 
Soderholm et al., 2011) and collected samples for IF and immuno-
blots 1 h after γ-irradiation. IF indicated an increased number of 
p-KAP1 nuclear foci associated with the heterochromatin in IPZ-
treated cells, while KPT-330 treatment had an opposite effect 
(Figure 5D). Although this trend was reproducible, the frequency 
of the IPZ-induced p-KAP1 foci varied between experiments. How-
ever, consistent with the IF data, immunoblotting showed that 
treatment with IPZ induced increased p-KAP1 signal upon irradia-
tion, particularly in hTERT-RPE1RCC1-V5 cells (Figure 5, E and F). Also 
in agreement with the IF data, KPT-330 caused a strong reduction 
in p-KAP1 signal and a more moderate decrease in γH2AX signal 
on immunoblots (Figure 5, E and F). Reciprocal effects of the in-
hibitors indicate that the interplay between exportin 1– and impor-
tin β–regulated NCT modulates the ATM-dependent phosphoryla-
tion of KAP1, which has a role in the heterochromatin DNA repair 
(White et al., 2012).
Because the activation of Ran promotes cell cycle progression 
(Figure 1), the RNAi knockdowns or inhibitor treatments described 
above could have induced cell cycle changes that contribute to the 
observed effects on DNA damage signaling and repair processes. 
However, the above results demonstrate that, whether directly or 
also through modulating the cell cycle, the activity of Ran⋅GTP-
regulated NCT mechanisms strongly affects essential steps of DDR 
in cell populations.
RCC1-induced activation of Ran-regulated 
NCT terminates DDR
The perturbations of DNA damage signaling induced by Ran or 
RCC1 knockdowns (Figure 5) indicate that the mechanism of RCC1-
induced recovery from DNA damage could require high Ran activity 
during the initial response to the damage. We examined this possi-
bility by manipulating Ran function in cells that already sustained γ-
irradiation–induced (10 Gy) DNA damage. First, we followed the ir-
radiation of the hTERT-RPE1WT cells by transduction with control or 
RCC1-V5–expressing lentiviruses (Figure 6A). As shown by the 
strongly reduced expression of S-phase and G2/M markers (MCM2, 
pS10H3), the majority of irradiated control cells stopped proliferat-
ing, as expected. The rise of transiently expressed RCC1-V5 was 
paralleled by a drop in cyclin D1 levels, and the renewed expression 
of interphase and mitotic markers (MCM2, pS10H3; Figure 6A), indi-
cating cell cycle reentry. This result showed that the activation of Ran 
in cells recovering from DNA damage is sufficient to terminate the 
DDR and enable the continuation of cell proliferation (Figure 5).
To determine whether RCC1-induced DDR termination requires 
the function of exportin 1, we treated γ-irradiated hTERT-RPE1RCC1-V5 
cells with KPT-330. The untreated hTERT-RPE1RCC1-V5 cells returned 
to cell cycle after irradiation, as shown by the expression of MCM2, 
pS10H3, and cyclin B1 (Figure 6B). KPT-330 treatment robustly re-
versed these trends and induced the accumulation of cyclin D1, in-
dicating that DDR termination requires exportin 1– dependent nu-
clear export.
To verify that Ran mediates RCC1-induced DDR termination, we 
treated irradiated hTERT-RPE1RCC1-V5 cells with control or Ran-di-
rected RNAi. As expected, RNAi controls resumed the cell cycle, as 
indicated by increased pS10H3 signal and reexpression of the Chk1 
kinase, whose activity is essential for S-phase progression (Toledo 
et al., 2013; Figure 6C). The treatment with Ran RNAi in hTERT-
RPE1RCC1-V5 cells reduced Ran levels by ∼50% (Figure 6C). However, 
even the partial reduction in Ran expression induced severe delays 
in DNA repair, as shown by the persistence of phosphorylated ATM 
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late the timing of the activation of the cyclin B/CDK1 and Gwl/Mastl 
kinases during entry into mitosis. The loss of RCC1 function in tem-
perature-sensitive tsBN2 cells induced premature entry to mitosis 
via the nuclear accumulation of the CDC25B phosphatase (Ohtsubo 
et al., 1987; Nishijima et al., 1997; Karlsson et al., 1999). Therefore 
the CDC25 phosphatase family could have a role in the Ran-regu-
lated cell cycle rate. Because the phosphatases Wip1 and PP4 pro-
mote the termination of DDR signaling (Kleiblova et al., 2013; 
Shaltiel et al., 2014), the potential involvement of NCT in their acti-
vation is also of interest.
As indicated by the studies of Ran function in aging cells (Snow 
et al., 2013), large size could be one of the common features of 
cargoes whose NCT is particularly sensitive to Ran activity. Consis-
tent with this idea, we observed that the knockdown of Ran induced 
cytoplasmic accumulation of 53BP1 (240–250 kDa; Figures 3, 5, and 
of the cell cycle. However, it remains possible that the rate of cell 
cycle transitions could be particularly sensitive to NCT of only a sub-
set of essential cargoes. The identity of such cell cycle rate-limiting 
NTR cargoes is not known, although published literature offers a list 
of many candidates. During the G1/S transition, such cargoes could 
include the mRNAs for many cyclins, including cyclin D1, whose 
eIF4e adaptor-dependent nuclear export requires exportin 1 
(Culjkovic et al., 2006; Osborne and Borden, 2015). The S-phase 
entry and transition also involve Ran in the nuclear–cytoplasmic 
shuttling of proteins of the cyclin D, A, and E families (Malumbres 
and Barbacid, 2001; Jackman et al., 2002). Exportin 1 is required for 
the nuclear–cytoplasmic shuttling of cyclin B1 (Toyoshima et al., 
1998; Gavet and Pines, 2010) and the Gwl/Mastl kinase that sup-
ports the function of the CDK1/cyclin B1 kinase (Alvarez-Fernandez 
et al., 2013; Wang et al., 2013). Potentially, Ran activity could modu-
FIGURE 6: RCC1-induced activation of NCT promotes the completion of the DNA repair and cell cycle reentry. 
(A–C) Immunoblots showing the changes of the cell cycle and DDR markers in cells exposed to different treatments 
after the γ-irradiation (10 Gy). (A) The γ-irradiated hTERT-RPE1WT cells were transduced with control or RCC1-V5 
expressing lentiviruses. (B) The γ-irradiated hTERT-RPE1RCC1-V5 cells were treated with dimethyl sulfoxide (control) 
or 500 nM KPT-330. (C) Control or Ran-directed RNAi was applied after the γ-irradiation of the hTERT-RPE1RCC1-V5 cells. 
(D) Micrographs of 53BP1 and γH2AX IF staining in the hTERT-RPE1RCC1-V5 treated as in C. Inset with the enhanced 
contrast shows the accumulation of the cytoplasmic 53BP1 signal in the Ran RNAi-treated cells (arrows). (E) Scatter plot 
of the cytoplasmic/nuclear ratios of the 53BP1 IF signal in the control or Ran RNAi-treated cells at 7 d of recovery from 
the γ-irradiation. Individual cell data; means ± SD; t test, representative of two experiments. (F) Fractions of hTERT-
RPE1WT and hTERT-RPE1RCC1-V5 cells recovering from γ-irradiation that contained the indicated numbers of 53BP1 foci 
per nucleus. Means ± SD from two independent experiments; two-way ANOVA with Bonferroni’s posttest.
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count and average diameter were determined with Cellometer Auto 
T4 (Nexcelom, Lawrence, MA). The PDT was calculated from the 
growth curves using the equation PDT = t × log(2)/[(log(Ct) − log(C0))], 
where t is the time of culture, Ct is the cell count at time t, and C0 is 
the cell count at the initial t = 0. t = 0 was selected as the first time 
point after the initial decline in cell number after plating.
Recombinant constructs
The pLenti-PGK-RCC1-V5 construct (pK439) was prepared by the 
modification of the PGK-histone H2B-mCherry (21217; Addgene, 
Cambridge, MA; Kita-Matsuo et al., 2009). Using PCR cloning and 
restriction digests, the histone H2B was replaced with an RCC1 
open reading frame. The resulting pLenti-PGK-RCC1-mCherry was 
digested with ScaI and SacII and ligated with the ScaI and SacII frag-
ment from pLenti X2 Blast (17391; Addgene; Campeau et al., 2009), 
introducing blasticidin resistance. mCherry was excised with Age1 
and BsRG1 and replaced with a V5 sequence-coding oligo. The 
construct was validated by sequencing.
Lentiviral expression of RCC1-V5
Lentiviruses for the expression from pLenti-PGK-RCC1-V5 were pro-
duced as previously described (Kalab et al., 2006; Hasegawa et al., 
2013). For transduction, normal cell media was replaced with media 
supplemented with lentiviral suspension (50–100 μl/ml) and 0.6/μl 
Polybrene/ml (Sigma-Aldrich). Following overnight treatment, cells 
were washed with warm DPBS (Life Technologies) and returned to 
normal growth medium. Stably expressing cells were selected by 
culture in media containing 10 μg/ml blasticidin. For transient ex-
pression, cells were transduced with pLenti-PGK-RCC1-V5 lentivirus 
6 h after irradiation.
Induction of senescence by replicative exhaustion 
or DNA damage
For induction of senescence by replicative exhaustion, HFF-1 cells 
were kept in culture until passage 30. For induction of DNA damage 
by doxorubicin, normal cell media was supplemented with doxoru-
bicin; this was followed by washes with warm DPBS and return to 
normal media. HFF-1, HCT116WT, HCT116RCC1-V5, CRL1474, and 
Wi38 cells were treated with 100 nM doxorubicin for 24 h. The 
hTERT-RPE1WT and hTERT-RPE1RCC1-V5 cells were treated for 16 h 
with 500 nM doxorubicin. For γ-irradiation–induced DNA damage, 
we used a J. L. Shepherd & Associates (San Fernando, CA) Mark-1-
Model 68 Irradiator with a concealed 137Cs source and calibrated 
lead shields to modulate the dose.
SABG staining
We used a previously described protocol (Debacq-Chainiaux et al., 
2009) to detect β-galactosidase activity. Bright-field micrographs 
were acquired using a Nikon Digital Sight color camera on a Nikon 
Eclipse T5100 microscope.
Electrophoresis and immunoblotting
For Supplemental Figures S1 and S2, cells were harvested and cell 
lysates were prepared for electrophoresis as described previously 
(Kalab et al., 2006; Hasegawa et al., 2013). For all other experiments, 
cells were trypsinized, washed in 37°C FBS-containing growth media, 
resuspended in 30–100 μl Clear Sample Buffer (CSB; 120 mM Tris, 
pH 6.8, 4% SDS, 20% glycerol), and immediately heated at 100°C for 
5 min. Protein concentration was measured using a Micro BCA Pro-
tein Assay Kit (Pierce Thermo-Fisher, Carlsbad, CA) and adjusted to 
4 mg/ml with CSB. Before electrophoresis, samples were mixed 1:1 
with SDS-free CSB, 10% β-mercaptoethanol, and 0.5% bromophenol 
6). In addition to 53BP1, many other prominent DNA repair regula-
tors are large, multidomain proteins whose nuclear import, and po-
tentially also export, could depend on sufficient Ran⋅GTP levels. 
However, the NCT of only a few of these regulators was studied in 
detail (53BP1; Moudry et al., 2012), TopBP1 (179 kDa; Bai et al., 
2014), and BRCA1 (220 kDa; Thompson, 2010).
In addition to its role in NCT, the activation of Ran could promote 
changes in cell cycle or DDR indirectly, through gene expression 
changes induced by the NCT of transcriptional and epigenetic fac-
tors (Nemergut et al., 2001; Turner et al., 2012; Muqbil et al., 2014). 
Such transcriptionally mediated effects of Ran possibly contribute to 
the activation of the cell cycle and DDR in RCC1-overexpressing cell 
lines. However, our results indicate that, even within the potentially 
diverse cellular context of cells with different RCC1 expression 
(Figures 5 and 6), the activity of the Ran-regulated NCT pathways 
was still required for the cellular response to DNA damage.
The crucial role of cellular RCC1 concentrations is a salient fea-
ture of the Ran system, as shown by computational modeling (Figure 
1 and Supplemental Figure S1) and our results. Because RCC1-me-
diated guanine nucleotide exchange reaction on Ran is the slowest 
step in the GTP/GDP cycle on Ran (Supplemental Figure S1), exces-
sive RCC1 concentration sequesters Ran, explaining the saturable 
effect of RCC1 expression on Ran⋅GTP (Supplemental Figure S1). 
Interestingly, RCC1 overexpression in normal cells (Figure 3) or high 
endogenous RCC1 expression in carcinoma cells (Figure 4) stabi-
lized endogenous Ran levels in cells recovering from DNA damage. 
The underlying mechanism remains to be determined. However, the 
computational models of the Ran system predict that changes in 
RCC1 expression are amplified through such coregulation, expand-
ing the amplitude of cellular Ran⋅GTP levels and their cellular ef-
fects. Consequently, DNA damage–induced decline of RCC1 in nor-
mal cells could lead to a severe impairment of NCT function as 
documented by the stalled nuclear import of 53BP1 (Figures 3 and 
6). Because cell cycle reentry requires Ran⋅GTP-dependent NCT ac-
tivity, the depletion of Ran⋅GTP levels could function as a universal 
mechanism that enforces stable cell cycle arrest in senescent cells.
MATERIALS AND METHODS
Cell culture
Human foreskin fibroblasts (HFF-1) from the American Type Culture 
Collection (ATCC, Manassas, VA), hTERT-immortalized retinal pig-
ment epithelial cells (hTERT-RPE1; ATCC), and human embryonic 
kidney cells, 293FT (HEK-293FT; Invitrogen) were cultured as previ-
ously described (Kalab et al., 2006; Hasegawa et al., 2013). Human 
colorectal carcinoma HCT116 cells were cultured in DMEM with 
10% fetal bovine serum (FBS). Normal human fibroblasts CRL1474 
(ATCC) were cultured in MEM with 15% FBS and normal lung fibro-
blasts Wi38 (ATCC) in MEM with 10% FBS. Media of cells expressing 
RCC1-V5 was supplemented with 10 μg/ml blasticidin (Invitrogen). 
All cells were grown in a 37°C humidified incubator with 5% CO2 
and in media supplemented with 100 U/ml penicillin and 10 μg/ml 
streptomycin. Cells were treated with Importazole (IPZ; Sigma-
Aldrich, St. Louis, MO; final concentration 40 μM) and KPT-330 
(Karyopharm, Newton, MA; final concentration 500 nM) by supple-
menting their complete cell culture with aliquots of 10 mM solutions 
of the drugs in dimethyl sulfoxide.
Cell count and cell volume measurement
For cell count measurement, aliquots of 50,000 cells/well were 
seeded in six-well plates. At different time points, cells were collected 
by trypsinization, washed in Dulbecco’s phosphate-buffered saline 
(DPBS), and fixed in Trypan Blue (15250; Invitrogen) before the cell 
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γH2AX images, and Excel was used to calculate the ratios of aver-
age 53BP1 and γH2AX signal for each nucleus.
Immunoblotting quantification
To quantify protein expression on immunoblots, we used Odyssey, 
version 3 (LI-COR). The background-subtracted signal of individual 
protein bands was normalized to the GADPH or tubulin signal that 
was detected in the same lane.
Simple Western analysis
Simple Western (ProteinSimple, San Jose, CA) analyses were per-
formed as previously described (Chen et al., 2013). Cell lysates (20 
or 40 ng protein/capillary) were mixed with 1X SDS sample buffer, 
dithiothreitol, and fluorescent standards (ProteinSimple); heated at 
70°C for 10 min before loading into the Peggy Sue instrument; 
separated by molecular weight; and immobilized using UV light. 
The capillaries were incubated with a blocking reagent (Protein-
Simple), followed by primary and horseradish peroxidase–conju-
gated secondary antibodies (Jackson ImmunoResearch, West 
Grove, PA). A chemiluminescence signal was developed, captured 
by a CCD camera, and quantified as the peak area by the Compass 
software according to the ProteinSimple protocols. The primary an-
tibodies used were Ran (610340; BD Biosciences), RCC1 (63356; 
GeneTex), cyclin D1 and cyclin B1 (sc-753 and sc-752; Santa Cruz 
Biotechnology), and vinculin (V9131; Sigma-Aldrich).
FACS analysis
Cells (500 μl of suspension in DPBS) were fixed with 4.5 ml ice-
cold 70% ethanol, centrifuged (1200 rpm, 5 min, 4°C), washed 
with 5 ml ice-cold DPBS (1200 rpm, 5 min, 4°C), resuspended in 
1 ml staining solution (20 μg/ml propidium iodide [PI; Sigma-
Aldrich], 200 μg/ml RNaseA [Sigma-Aldrich], 0.1% Triton X-100/
PBS), and incubated for 30 min at 37°C. After filtration with 
70-μm nylon mesh, cells were sorted using FACSCalibur 
(Becton-Dickinson, Franklin Lakes, NJ). Cell debris and doublets 
were gated out, and G0/G1, S, and G2/M populations were 
quantified using the ModFit, version 3.0 (Becton-Dickinson). 
Images showing the total PI signal count versus count distribu-
tion were displayed using FlowJo-VX.
RCC1 and Ran RNAi
Control siRNA oligo (5′-UGGUUUACAUGUCGACUAA-3′; ON-
TARGET plus nontargeting siRNA #1), RCC1 siRNA SMARTpools 
(5′-GGAGAACCGUGUGGUCUUA-3′, 5′-CAGCAGCCC UCA CCG-
AUGA-3′, 5′-GCACAGAACCCGGCUUGGU-3′ and 5′-GGACAA-
UAACGGUGUGAUU-3′; Chen et al., 2007), and Ran siRNA 
(5′-GAAAUUCGGUGGACUGAGA-3′ and 5′-CCAACAGAGGAC-
CUAUUAA-3′) were obtained from Thermo-Fisher/Dharmacon. HC-
T116WT or hTERT-RPE1RCC1-V5 cells were plated in six-well plates or 
100-mm dishes in antibiotic-free medium and transfected with a 
5 nM final siRNA concentration using Dharmafect (Thermo-Fisher) 
according to manufacturer’s instructions.
FLIM imaging, analysis, and display
Spatially resolved, time-correlated single-photon counting (TCSPC) 
data sets were acquired as described previously (Kalab et al., 2006; 
Hasegawa et al., 2013), using a Zeiss LSM710 NLO (Zeiss USA, 
Thornwood, NY) microscope equipped with an SPC-830 (Becker & 
Hickl GmbH, Berlin, Germany) TCSPC controller. Imaging condi-
tions were chosen to limit the emission to (0.2–1) × 106 counts/s. 
Images of 128 × 128 pixels (1024 time bins/pixel) were acquired 
over 60–120 s and analyzed with SPCI software (Becker & Hickl), 
blue and heated at 100°C for 2 min. For Supplemental Figures S1 
and S2, proteins were separated by homemade SDS–PAGE gels 
(Hasegawa et al., 2013). In all other experiments, we used 4–20% 
Criterion gels (Bio-Rad, Hercules, CA). Gels were blotted to polyvi-
nylidene difluoride transfer membrane (Immobilon-FL; MIllipore, 
Bedford, MA) or LI-COR Odyssey (LI-COR Biotechnology, Lincoln, 
NE) nitrocellulose. Immunoblots were blocked and incubated with 
primary antibodies and IRDye 800– and/or IRDye 680–conjugated 
donkey secondary antibodies using Li-COR Odyssey buffers and pro-
tocols. The fluorescence emission was acquired using the Odyssey 
Imaging System (LI-COR). For each primary antibody, tubulin, actin, 
GAPDH, or Ponceau S–stained images of the blots were used as a 
loading control. The primary antibodies used for immunoblotting 
were from BD Biosciences (San Jose, CA; Ran, 610340; importin β, 
610559), Bethyl (Montgomery, TX; Ran, A304-298A-M; p-
KAP1(Ser-824), A300-767A; ATM, A300-136A), Genetex (Irvine, CA; 
RCC1,GTX63356; MCM2, GTX6238; cyclin B1, GTX6139; p-ATM 
(Ser-1981), GTX61739), Novus Biologicals (Littleton, CO; 53BP1, 
NB100-304), Santa Cruz Biotechnology (Dallas, TX; RanGAP1, sc-
1862; cyclin D1, sc-753; GAPDH, sc-32233; Rad51, sc-8349; RanBP2, 
sc-74518; 53BP1, sc-22760; Chk1, sc-8408), Abcam (Cambridge, 
MA; RCC1, ab109379; TPX2 ab32785), Cell Signaling Technology 
(Danvers, MA; RanBP1, 8780; Chk2, 3440), Epitomics (Burlingame, 
CA; pS10H3, 1173-1), Developmental Studies Hybridoma Bank 
(Iowa City, IA; tubulin E7, E7), Millipore (γH2AX(Ser-193), 05-636), 
and GenScript (Piscataway, NJ; β-actin, A00702).
IF
Cells were grown on cleaned 12-mm round coverslips or on 32-mm 
ibidi chambers for RNAi-treated cells. For most experiments, cells 
were prepared for IF as previously described (Hasegawa et al., 
2013), using antibodies to γH2AX (05-636; Millipore), 53BP1 (sc-
22760; Santa Cruz Biotechnology), and p-KAP1 (A300-767A; 
Bethyl). For the detection of 53BP1 recruitment to γH2AX (Figure 
5B), cells were fixed in 4% paraformaldehyde and 1% Triton X-100 
in PBS for 10 min at room temperature.
53BP1 nuclear foci counting
The cells stained for 53BP1 and γH2AX were photographed on a 
wide-field Olympus IX81 microscope (Olympus USA, Waltham, MA) 
equipped with a UplanSApo 60×/1.35 oil-immersion lens and a Hama-
matsu C4742 charge-coupled device (CCD) camera. For each sample, 
we acquired images of the DNA stain (Hoechst-33342), 53BP1 and 
γH2AX in at least 85 cells in randomly selected fields. Using the γH2AX 
foci as a control for a DNA damage–specific signal, the number of 
53BP1 foci detected in each nucleus was manually counted and re-
corded in Excel spreadsheets by at least two independent observers.
IF quantification
MetaMorph 7.0.5 (Molecular Devices, Sunnyvale, CA) was used to 
quantify the IF signal intensity in images acquired using the Up-
lanSApo 60×/1.35 oil-immersion lens and the Hamamatsu C4742 
CCD camera. IF staining was performed as described above. Before 
quantification, the image-specific average out of cell fluorescence 
was subtracted from all images. For quantification of the cellular 
distribution of 53BP1, DNA images were thresholded for light ob-
jects to enable automatic creation of nuclear regions that were then 
transferred to 53BP1 images. After cytoplasmic 53BP1 regions for 
each cell were manually selected, region measurement data for 
each cell was logged into Excel, and the ratio of the average cyto-
plasmic and nuclear signal was calculated. Similarly, for Figure 5C, 
the DNA signal was used to create nuclear regions in the 53BP1 and 
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